11 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

INNOLATEX MALE LATEX CONDOMS COLORED AND SCENTED

FDA 510(k)
FDA Class 2 ·Obstetrics/Gynecology

NA

FDA UDI
Exactech, Inc.·10885862606983·ANT APPROACH CORKSCREW

TORNIER AEQUALIS REVERSE SHOLDER PROSTHESIS

FDA Adverse Event
Malfunction ·TORNIER INC.·Product code HSD·June 18, 2009

LIFECARD CF 7 DAY

FDA 510(k)
FDA Class 2 ·Cardiovascular

NITRILE EXAMINATION GLOVES, PRE-POWDERED, COLOR BLUE

FDA 510(k)
FDA Class 1 ·General Hospital

OT VERIO IQ METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·April 8, 2013

INSIGNIA

FDA Adverse Event
Injury ·GUIDANT CLONMEL IRELAND·Product code NVZ·April 6, 2011

CONTAK RENEWAL 4

FDA Adverse Event
Malfunction ·CARDIAC PACEMAKERS, INC·Product code NIK·May 8, 2008

VIASYS

FDA Adverse Event
Other ·CAREFUSION 207, INC·Product code CBK·October 27, 2009

The Spirit Plus Bed, Model 5600 Spirit Plus /with high rail siderail option

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·November 21, 2018

Quadra Assura, Model No. CD3265-40, CD3265-40Q, CD3365-40C, CD3365-40Q. Quadra Assura MP, Model No. CD3269-40, CD3269-40Q, CD3369-40C. Fortify and Fortify Assura implantable cardioverter defibrillators (ICDS) are intended to provided ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing. Unify and Unify Assura cardiac resynchronization therapy defibrillators (CRTDs) are intended to provide ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing, in additional to cardiac resynchronization therapy via left ventricular pacing

FDA Enforcement
Class I ·Terminated·St Jude Medical Inc.·November 2, 2016